Related Experiment Video
Updated: Aug 5, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Hyperlipidemia Management: Comprehensive Review and Looking Forward
Whitnee Otto1,2, Muhammad Hasan3, Maria Stys2,4,5
1Cardiovascular Disease Fellowship Program, University of South Dakota Sanford School of Medicine.
Summary
Hyperlipidemia increases cardiovascular disease risk. New therapies like PCSK9 inhibitors, ezetimibe, bempedoic acid, and inclisiran offer effective options for patients needing more than statins to lower LDL cholesterol.
Area of Science:
- Cardiology
- Metabolic Diseases
- Pharmacology
Background:
- Hyperlipidemia is a primary risk factor for atherosclerotic cardiovascular disease (ASCVD).
- Statins are the primary treatment, but some patients need additional therapies for better low-density lipoprotein cholesterol (LDL-C) control.
- Personalized, patient-centered approaches are increasingly emphasized in lipid management.
Purpose of the Study:
- To review recent advancements in lipid metabolism research.
- To explore novel adjunctive agents for hyperlipidemia management.
- To highlight therapies improving cardiovascular outcomes beyond statins.
Main Methods:
- Literature review of recent advancements in lipid metabolism.
- Analysis of clinical trial data for adjunctive lipid-lowering agents.
- Synthesis of evidence on efficacy and cardiovascular benefits.
Main Results:
- Emerging agents like PCSK9 inhibitors, ezetimibe, bempedoic acid, and inclisiran show significant LDL-C reduction.
- These therapies provide effective options for statin-intolerant or non-responsive patients.
- Improved lipid profiles correlate with better cardiovascular outcomes.
Conclusions:
- Recent lipid metabolism research has yielded effective adjunctive therapies for hyperlipidemia.
- PCSK9 inhibitors, ezetimibe, bempedoic acid, and inclisiran represent important advancements in cardiovascular risk reduction.
- Personalized treatment strategies incorporating these agents can optimize patient care.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...